Skip to content

Clinical trials

Phase 1 Attention Deficit Disorder with Hyperactivity trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Attention Deficit Disorder with Hyperactivity Phase: Phase 1 Clear all

72 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20052
20081
20097
20104
20114
20122
20135
20144
20155
20162
20174
20184
20193
20204
20213
20234
20244
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed52
Unknown status9
Terminated4
Not yet recruiting3
Enrolling by invitation2
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Otsuka Pharmaceutical Development & Commercialization, Inc.8
Shire4
PhenoSolve, LLC3
Yale University3
Aevi Genomic Medicine, LLC, a Cerecor company2
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.2
Massachusetts General Hospital2
Spanish Foundation for Neurometrics Development2
The National Center on Addiction and Substance Abuse at Columbia University2
University of California, Los Angeles2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Attention Deficit Disorder with Hyperactivity72
Conduct Disorder2
Narcolepsy2
Oppositional Defiant Disorder2
Alcoholism1
Anemia, Sickle Cell1
Anxiety Disorders1
Autism Spectrum Disorder1
Autistic Disorder1
Binge-Eating Disorder1

Trials

Showing 1 to 25 of 72. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.